20 Nov 2018 | 4:22 AM
 

Suven Life Sciences Ltd. Share Price Live (BSE)
0

BSE Code: 530239 | NSE Symbol: SUVEN
247.30
-0.15
(-0.06 %)
19 Nov 2018 | 03:53 PM
Change company
  • Open (Rs)
    247.45
  • Prev. close (Rs.)
    247.45
  • High (Rs.)
    253.85
  • Low (Rs.)
    245.65
  • 52W H (Rs.)
    319.00
  • 52W L (Rs.)
    163.31
  • Volume
    64608
  • MCap (Rs in Cr.)
    3,147.69
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
9.72
Operating Margin (%)
31.69
Gross Profit Margin (%)
28.28
Net Profit Margin (%)
19.78
Total Debt/Equity
0.03
Dividend payout Ratio (Net Profit)
18.57
Earning Retention Ratio
81.43

News

06 Nov 2018 - 14:24:00-Suven Life Sciences Tuesday said it has been granted a product patent each by Israel and Japan for a...
25 Sep 2018 - 12:20:00-Suven Life Sciences Tuesday said it has been granted a product patent by Canada and Sri Lanka each f...
14 Sep 2018 - 13:26:00-Suven Life Sciences Friday said it has been granted a product patent by New Zealand and Sri Lanka co...
11 Sep 2018 - 11:46:00-Shares of Suven Life Sciences rallied nearly 6 per cent hitting 52-week high on Bombay Stock Exchang...

Announcements

14-Nov-2018
Suven Life Sciences - Outcome of Board Meeting
14-Nov-2018
Suven Life Sciences - Appointment
14-Nov-2018
Suven Life Sciences - Announcement under Regulation 30 (LODR)-Change in Directorate
14-Nov-2018
Suven Life Sciences - Investor Presentation
14-Nov-2018
Suven Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation

Religare Research

19 Nov 2018 | 07:37 PM
December gold futures ended up 0.66% at $1,223.00 on the Comex division of the New York Mercantile E...
19 Nov 2018 | 07:00 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
19 Nov 2018 | 03:31 PM
Symphony Ltd reported mix set of numbers for Q2FY19. While revenue growth was in-line with our proje...
19 Nov 2018 | 11:32 AM
Highlights : • Moderate weakness was shown for most Agri counters as profit booking set in for the ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
52,39,040 114.42 32.52 0.15
52,39,040 114.42 88.22 0.16
52,39,040 114.42 26.13 0.82
52,39,040 114.42 57.53 0.82
52,39,040 114.42 92.04 0.16

Shareholding Pattern

       
Promotors60.00%
Mutual Funds/UTI1.51%
FI/Banks0.58%
Insurance0.58%
FII5.83%
Government0.00%
Others9.67%

Peer Group

Company Intraday Graph
 Merck Ltd.
2,961.80(-2.17)
3302
 AstraZeneca Pharma India Ltd.
1,647.60(-0.70)
3274
 Dr. Lal Pathlabs Ltd.
837.75(0.13)
17140
 Ipca Laboratories Ltd.
763.00(0.65)
3488

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Suven Life Sciences Ltd.4.3015.4566.85
NIFTY(S&P CNX)459.85-788.35246.70
BSE SENSEX1,459.25-2,503.871,158.75
BSE 500641.32-1,259.84-103.06

Corporate Details

Key Personal
Santanu Mukherjee
Ind. Non-Executive Director
Sudha Rani Jasti
Whole Time Director
Venkateswarlu Jasti
Chairman & CEO
Key Address
Registered Office
# 8-2-334 SDE Serene Chambers 6th Floor Avenue 7 Road No. 5 Banjara Hills,Hyderabad,Telangana

Tel:40-23541142 23543311 23543315, Fax:40-23541152

investorservices@suven.com
http://www.suven.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda